Xtandi 80 MG tab 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTJD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,783
Award facts
- Contract value 100% obligated
- $12,783.08 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,783.08 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Xtandi 80 mg. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award carries an ultimate completion date of January 12, 2026, and represents a routine pharmaceutical supply transaction supporting Department of Defense medical operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent IDC, awarded November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy. This contract structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for diverse pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to support recurring medical supply needs of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FBTJD?
SPE2DR26FBTJD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FBTJD worth?
The government has obligated $12,783 on SPE2DR26FBTJD.
Is contract SPE2DR26FBTJD an order under another contract?
Yes. SPE2DR26FBTJD is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTJD competed?
The extent of competition for SPE2DR26FBTJD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award